ZEMANOVÁ, Z., K. MICHALOVÁ, J. TAJTLOVÁ, J. PAVLIŠTOVÁ, A. OLTOVÁ, H. FILKOVÁ, P. KUGLÍK, P. NĚMEC, D. KRÁLOVÁ, M. HOLZEROVÁ, J. BALCARKOVÁ, M. JAROŠOVÁ, J. RABASOVÁ, M. HRUBÁ, H. FISCHLOVÁ, I. ŠPIČKA, E. GREGORA, Z. ADAM, V. ŠČUDLA, V. MAISNAR and M. SCHUTZOVÁ. Molecular cytogenetic study of immunofluerescently labeled plasma cells and prognostic significance of clonal chromosomal aberrations in 208 Patients with multiple myeloma. Hematologica the hematology journal. 2008, vol. 93, No 1, p. 65-66. ISSN 0390-6078.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Molecular cytogenetic study of immunofluerescently labeled plasma cells and prognostic significance of clonal chromosomal aberrations in 208 Patients with multiple myeloma
Authors ZEMANOVÁ, Z., K. MICHALOVÁ, J. TAJTLOVÁ, J. PAVLIŠTOVÁ, A. OLTOVÁ, H. FILKOVÁ, P. KUGLÍK, P. NĚMEC, D. KRÁLOVÁ, M. HOLZEROVÁ, J. BALCARKOVÁ, M. JAROŠOVÁ, J. RABASOVÁ, M. HRUBÁ, H. FISCHLOVÁ, I. ŠPIČKA, E. GREGORA, Z. ADAM, V. ŠČUDLA, V. MAISNAR and M. SCHUTZOVÁ.
Edition Hematologica the hematology journal, 2008, 0390-6078.
Other information
Type of outcome Article in a journal
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 5.978
Organization unit Faculty of Medicine
UT WoS 000263430200165
Changed by Changed by: Jitka Drncová, učo 109799. Changed: 31/3/2009 08:28.
Links
MSM0021622434, plan (intention)Name: Od klasických prognostických markerů ke klinicky aplikovatelným farmakogenomickým a farmakoproteomickým projektům u mnohočetného myelomu a monoklonálních gamapatií
Investor: Ministry of Education, Youth and Sports of the CR, From classic prognostic markers to clinical applications in selected pharmacogenomic and pharmacoproteomic projects in multiple myeloma and monoclonal gammapathies
PrintDisplayed: 28/9/2024 13:43